This article was originally published on The limbic Subcutaneous daratumumab with pomalidomide and dexamethasone (D-Pd) is an effective and...
Research
Phase III Trial Supports Efficacy of Subcutaneous Daratumumab in Relapsed/Refractory Myeloma
This article was originally published on Ash Clinical News Patients with relapsed/refractory multiple myeloma (MM) who were treated with a...
Year in Review: Multiple Myeloma
This article was originally posted on MEDpage Today Despite some concern over a novel ocular toxicity, the FDA granted accelerated...
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies
This article was originally published on Multiple Myeloma Today ABSTRACT BACKGROUND: Patients with hematological malignancies (HM), including...
MM management in Australia lags behind other countries due to reimbursement model
This article was originally published on The Limbic Australian patients with multiple myeloma face critical shortcomings in genetic testing at...
Bridging Radiation Therapy Safe, Feasible for Patients with R/R Multiple Myeloma
This article was originally published on Cancer Network Results from a study presented at the American Society for Radiation Oncology (ASTRO) Annual...
Multicenter Study of Spanish Patients Provides New Insights on COVID-19 in Multiple Myeloma
This article was originally published on Cancer Therapy Advisor As the coronavirus disease 2019 (COVID-19) pandemic evolves into subsequent waves in...
Multiple myeloma-A painful disease of the bone marrow
This article originally published on Multiple Myeloma Toady ABSTRACT Multiple myeloma is a bone marrow neoplasia with an incidence of 6/100,000/year...
Hematologist Discusses the Multiple Myeloma Pipeline
This article was originally published on Docwire News Sarah Holstein, MD, PhD, associate professor of medicine in the Division of Oncology &...
Saad Usmani Discusses Treatments in Multiple Myeloma Patients.
This article was originally posted on Docwire News. DocWire News sat down with Saad Usmani, M.D., MBA, FACP to discuss an indirect treatment...
A Look at the Immunotherapy Pipeline for Multiple Myeloma
This article was originally published on Docwire News Nina Shah, MD, an associate professor in the Department of Medicine at the University of...
Optimal Strategies for Treatment of Multiple Myeloma in Newly Diagnosed Patients
This article was originally published on Targeted Oncology The multiple myeloma treatment paradigm has seen an assortment of therapeutic advances in...